Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

Clinical Trial Description

The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01179412
Study type	Interventional
Source	Mahidol University
Contact
Status	Completed
Phase	Phase 4
Start date	July 2004
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03055065` - ADenoVirus Initiative Study in Epidemiology in Italy	N/A
Completed	`NCT01977443` - Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)	Phase 2
Terminated	`NCT03861728` - Viral Conjunctivitis Treatment Study	N/A
Completed	`NCT02054234` - ADenoVirus Initiative Study in Epidemiology in France	N/A
Completed	`NCT02254330` - ADenoVirus Initiative Study in Epidemiology in Spain	N/A
Completed	`NCT02112773` - ADenoVirus Initiative Study in Epidemiology in UK	N/A
Completed	`NCT01481519` - A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis	Phase 3
Completed	`NCT02054273` - ADenoVirus Initiative Study in Epidemiology in Germany	N/A